Cervicovaginal HPV Infection in Female Renal Transplant Recipients: An Observational, Self-Sampling Based, Cohort Study

K. A. P. Meeuwis*, L. B. Hilbrands, J. IntHout, B. F. M. Slangen, I. M. P. Hendriks, F. Hinten, M. H. L. Christiaans, W. G. V. Quint, P. C. M. van de Kerkhof, L. F. A. G. Massuger, A. J. Hoitsma, M. M. van Rossum, W. J. G. Melchers, J. A. de Hullu

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Immunosuppressive treatment of organ transplant recipients is associated with an increase in the occurrence of human papillomavirus (HPV) related anogenital (pre)malignancies. This cohort study investigated the genotype-specific prevalence of HPV infections in a large cohort of female renal transplant recipients (RTRs). Participants self-collected a cervicovaginal sample for detection and genotyping of HPV. Besides, they completed a questionnaire regarding sociodemographic variables, medical data and sexual behavior. Anogenital screening was offered to all HPV-positive participants. A total number of 218 female RTRs was included. The prevalence of mucosal HPV infections was 27.1% and 17.4% for high risk HPV in particular. The studied cohort showed a broad range of HPV genotypes and multiple HPV genotypes were found in 27.1% of HPV-positive patients. Seven participants were identified with occult premalignant anogenital lesions. In conclusion, this study shows a high point-prevalence of HPV in female RTRs (age-matched West-European general population: 9-10%) with a shift in the distribution of genotypes as compared with the general population. Moreover, a substantial number of patients with occult premalignancies was identified. The introduction of self-sampling for HPV positivity can help in early detection of (pre)malignant anogenital lesions in this vulnerable population.
Original languageEnglish
Pages (from-to)723-733
JournalAmerican Journal of Transplantation
Volume15
Issue number3
DOIs
Publication statusPublished - Mar 2015

Keywords

  • Cancer
  • malignancy
  • neoplasia
  • clinical research
  • practice
  • infection and infectious agents
  • obstetrics and gynecology
  • viral: papillomavirus

Cite this